Amarin Corp Plc (AMRN): They did not really lock in a solid part...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Amarin Corp Plc (AMRN)

Reply Private New

Keep Last Read

Replies (4) Next 10 Prev Next

Send PM Follow Ignore

Followers	45
Posts	1535
Boards Moderated	0
Alias Born	11/25/2013

Re: mrmainstreet post# 436817

Tuesday, 06/24/2025 11:11:30 AM

Tuesday, June 24, 2025 11:11:30 AM

They did not really lock in a solid partner. They handed over the franchise to an independent company who now owns the rights for the EU for a minor 25 million upfront and some milestones and a small percentage probably around 15% in future income. Just like with.HLS which has complete autonomy from Amarin and only needs to purchase their product from Amarin and pay them a high teens royalty. HLS has complete autonomy over vascepa in Canada - within certain restrictions in their initial contract, and the same will be true for the new OWNER of the rights for V in EU.
Amarin no longer has the rights for V in EU.
EU is done

Keep Last Read

Replies (4) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent AMRN News

Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/01/2025 01:30:04 AM
Amarin Stock Surges 11% After $25 Million Licensing Deal with Recordati • IH Market News • 06/24/2025 02:09:36 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/24/2025 11:05:28 AM
Amarin Announces Exclusive License and Supply Agreement with Recordati to Commercialize VAZKEPA® (Icosapent Ethyl) in Europe • GlobeNewswire Inc. • 06/24/2025 11:00:00 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2025 11:05:23 AM
Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2025 11:05:10 AM
Amarin Reports First Quarter 2025 Financial Results • GlobeNewswire Inc. • 05/07/2025 11:00:00 AM
Form 8-K - Current report • Edgar (US Regulatory) • 04/29/2025 08:20:08 PM
Amarin Regains Compliance with Nasdaq Minimum Bid Price Requirement • GlobeNewswire Inc. • 04/29/2025 08:15:00 PM
Amarin to Report First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025 • GlobeNewswire Inc. • 04/28/2025 08:15:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/23/2025 01:00:12 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/23/2025 01:00:09 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/23/2025 01:00:09 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/23/2025 01:00:07 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/23/2025 01:00:06 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/23/2025 01:00:05 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/23/2025 01:00:05 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/23/2025 01:00:03 AM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/11/2025 10:00:07 PM
Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/10/2025 09:01:21 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/10/2025 11:30:16 AM
Form 8-K - Current report • Edgar (US Regulatory) • 04/09/2025 11:35:08 AM
Amarin Confirms Effective Date for 1-For-20 ADS Ratio Change • GlobeNewswire Inc. • 04/09/2025 11:30:00 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/09/2025 11:25:08 AM
Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 04/07/2025 11:50:42 AM

More AMRN News

InvestorsHub NewsWire

Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM

Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM

Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM

Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM

Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM

Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs • CLDI • Jul 7, 2025 9:00 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow